DJ AstraZeneca PLC ADR Falls Wednesday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
The AstraZeneca PLC ADR $(AZN)$ slipped 2.20% to $66.23 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.72% to 19,146.81 and the Dow Jones Industrial Average falling 0.21% to 42,051.06.
This was the ADR's second consecutive day of losses.
AstraZeneca PLC ADR closed 24.46% short of its 52-week high of $87.68, which the company reached on August 30th.
The ADR demonstrated a mixed performance when compared to some of its competitors Wednesday, as Eli Lilly & Co. $(LLY)$ fell 4.09% to $715.56, Biogen Inc. $(BIIB)$ fell 2.27% to $120.37, and Johnson & Johnson $(JNJ)$ fell 1.40% to $146.36.
Trading volume (5.6 M) remained 365,293 below its 50-day average volume of 6.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 14, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 14, 2025 17:22 ET (21:22 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.